Upregulation of MiR-196a promotes cell proliferation by downregulating p27kip1in laryngeal cancer.
BACKGROUND
Accumulating evidence has confirmed that miR-196a plays a critical role in tumorigenesis and tumor progression in a variety of cancers. It has been demonstrated that miR-196a is highly up-regulated in laryngeal cancer by miRNA profiling analysis. However, the functional mechanism of miR-196a in laryngeal cancer remains unclear. This study aims to explore the mechanism of miR-196a in laryngeal cancer.


METHODS
In the present study, we conducted qPCR analysis of miR-196a expression in human laryngeal cancer and showed that miR-196a was overexpressed in tumor-derived samples and laryngeal cancer cell lines compared with matched normal controls. Further functional analysis of miR-196a demonstrated that the inhibition of miR-196a could inhibit laryngeal cell-cycle progression and proliferation in vitro. Luciferase reporter assay and western blot confirmed that miR-196a directly targeted p27kip1. Moreover, in order to investigate whether miR-196a regulated cell growth in laryngeal cancer cells by targeting p27kip1, rescue studies were performed in laryngeal cancer cells.


RESULTS
Results showed that overexpression of p27kip1 rescue decreased cell proliferation caused by miR-196a inhibitors. A negative relation between miR-196a and p27kip1 expression in laryngeal cancer tissues were also noted by further analyses.


CONCLUSIONS
The present study showed that miR-196a was upregulated in laryngeal cancer and promoted cell proliferation by downregulating p27kip1 in laryngeal cancer. However, further studies are needed to verify this finding.
Department of Otorhinolaryngology, School of Medicine, Ren Ji Hospital, Shanghai Jiao Tong University, No.145 Pujian Road, Shanghai, 200127, China.
Cheng
C
Jin
Department of Otorhinolaryngology, School of Medicine, Ren Ji Hospital, Shanghai Jiao Tong University, No.145 Pujian Road, Shanghai, 200127, China.
Yi
Y
Zhang
Department of Otorhinolaryngology, School of Medicine, Ren Ji Hospital, Shanghai Jiao Tong University, No.145 Pujian Road, Shanghai, 200127, China. drlijiping@163.com.
Jiping
J
Li
Laryngeal cancer; miR-196a; p27kip1
J Radiat Res. 2016 Aug;57 Suppl 1:i106-i111
26983984
J Biol Chem. 1998 Jun 5;273(23):14424-9
9603954
PLoS One. 2010 Apr 14;5(4):e10147
20418948
JAMA. 2007 May 2;297(17):1901-8
17473300
Otolaryngol Clin North Am. 2008 Aug;41(4):673-95, v
18570953
Cell Biosci. 2016 Jan 26;6:6
26819702
Oncol Rep. 2015 Aug;34(2):877-83
26062455
Tumour Biol. 2016 Feb;37(2):2387-94
26376998
Nat Rev Genet. 2008 Feb;9(2):102-14
18197166
Cell. 2007 Dec 14;131(6):1109-23
18083101
Genes Dev. 1995 May 15;9(10):1149-63
7758941
Cell. 2004 Jan 23;116(2):281-97
14744438
J Invest Dermatol. 2000 Jan;114(1):157-64
10620132
Curr Opin Genet Dev. 2006 Feb;16(1):4-9
16361094
Int J Clin Exp Pathol. 2015 Mar 01;8(3):2461-72
26045752
Int J Mol Sci. 2016 Mar 11;17 (3):356
26978351
Cancer Biother Radiopharm. 2013 Mar;28(2):131-7
23134218
Nat Rev Cancer. 2006 Nov;6(11):857-66
17060945
Cell. 1996 May 31;85(5):733-44
8646781
Eur Arch Otorhinolaryngol. 2016 Sep;273(9):2747-54
26573156
Oncotarget. 2016 Feb 2;7(5):5972-84
26745603
Dev Biol. 2007 Feb 1;302(1):1-12
16989803
PLoS One. 2013 Aug 14;8(8):e71480
23967217
Mol Clin Oncol. 2016 Jan;4(1):70-76
26870361
Pancreas. 2012 Jul;41(5):671-7
22695087
Nat Rev Cancer. 2009 Apr;9(4):293-302
19262572
Cell Cycle. 2014;13(19):3100-11
25486569
Mol Cancer Ther. 2012 Apr;11(4):842-52
22343731